Skip to main content

Table 2 Types of Primary Outcome selected for use in Registered Trials for Posterior Segment Involving Uveitis (PSIU)

From: Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis

Type of Primary Outcomes

Design

Number (n/104)

Percentage (%)

Efficacy Outcome(s) Alone

Single efficacy outcome

36

35

Composite outcomes

35

34

Multiple efficacy outcomes

20

19

All

91

88

Safety Outcome Alone

All

10

10

Mixed efficacy and Safety Outcomes

Composite efficacy outcome with safety outcome

0

0

Multiple efficacy outcome with safety outcome

3

3

All

3

3